This website is intended exclusively for the Registered Medical Practitioners in India.

A recent head-to head trial comparing the effectiveness of valproate versus levetiracetam

SANAD II trial: Compares the long-term clinical effectiveness and cost-effectiveness of valproate vs levetiracetam in patients with newly diagnosed generalized or unclassified epilepsy.

MAT-IN-2200193

This website is intended exclusively for Registered Medical Practitioners in India.

Please select the tab below to continue.

You are now being redirected to a third-party website.

Sanofi does not endorse or approve the content, products, services or opinions on the third-party website. Sanofi shall not be responsible or in any way liable for any injury or damage to any persons in view of any reliance placed on or action taken basis of the information on the third party website or any errors, omissions or inaccuracies and/or incompleteness of the information on the third party website.

Proceed

A recent head-to head trial comparing the effectiveness of valproate versus levetiracetam

SCIENCE

PATIENT SUPPORT